Key Events This Week
27 Apr: Stock rallies 2.64% on technical improvements
28 Apr: Upgrade from Strong Sell to Sell by MarketsMOJO
29 Apr: Technical momentum shifts back to bearish, stock falls 2.49%
30 Apr: Week closes at Rs.322.00, down 0.45% on the day

Bajaj Healthcare Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-04-29 08:03:27Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish signals on weekly MACD and KST indicators, the overall technical landscape remains challenging, with key moving averages and monthly indicators signalling caution for investors.
Read full news article
Bajaj Healthcare Ltd Upgraded to Sell on Technical Improvements and Valuation Appeal
2026-04-28 08:45:08Bajaj Healthcare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by improvements in technical indicators amid persistent fundamental weaknesses. The company’s recent financial performance shows positive quarterly growth, yet long-term concerns remain, particularly regarding profitability trends and debt servicing capacity. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change.
Read full news article
Bajaj Healthcare Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-04-28 08:05:23Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day gain of 2.64% to close at ₹333.00, the stock’s technical indicators present a complex picture, reflecting mixed signals that investors should carefully analyse amid broader market conditions.
Read full news article
Bajaj Healthcare Ltd Faces Bearish Momentum Amid Technical Deterioration
2026-04-27 08:02:30Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling increased bearishness. The stock’s recent downgrade to a Strong Sell rating by MarketsMOJO, combined with deteriorating technical indicators, underscores mounting challenges for investors amid a volatile market backdrop.
Read full news articleBajaj Healthcare Falls 7.02%: 3 Key Factors Driving the Weekly Decline
2026-04-25 13:03:17
Key Events This Week
20 Apr: Stock opens at Rs.333.85, down 4.33% on heavy volume
21 Apr: Downgrade to Strong Sell rating announced
22 Apr: Technical indicators signal bearish momentum; stock closes at Rs.329.05
23 Apr: Mild technical recovery but overall bearish sentiment persists
24 Apr: Week closes at Rs.324.45, down 2.48% on the day

Bajaj Healthcare Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-04-23 08:03:16Bajaj Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a modest day gain of 1.16% to close at ₹332.75, the stock continues to face significant headwinds as reflected in its technical indicators and relative performance against the broader market benchmarks.
Read full news article
Bajaj Healthcare Downgraded to Strong Sell Amid Technical Weakness and Long-Term Challenges
2026-04-22 08:23:06Bajaj Healthcare Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 21 Apr 2026, driven primarily by deteriorating technical indicators and persistent fundamental weaknesses. Despite some positive quarterly financial results, the company’s long-term performance and valuation metrics have failed to inspire confidence among investors, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.
Read full news articleBoard Meeting Intimation for Consideration Of Financial Results
02-May-2026 | Source : BSEBajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 inter alia to consider and approve 1. Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 2. Recommend Final Dividend on Equity Shares if any for the Financial Year 2025-26 subject to the approval of Shareholders of the Company at the ensuing Annual General Meeting of the Company.
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
24-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Bajaj Healthcare Ltd |
| 2 | CIN NO. | L99999MH1993PLC072892 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 237.54 |
| 4 | Highest Credit Rating during the previous FY | INDA-Stable |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | INDIA RATINGS AND RESEARCH PVT. LTD. |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | MSEI |
Designation: Company Secretary and Compliance Officer
EmailId: investors@bajajhealth.com
Designation: Chief Financial Officer
EmailId: rohan.parekh@bajajhealth.com
Date: 24/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
Corporate Actions
(08 May 2026)
Bajaj Healthcare Ltd has declared 20% dividend, ex-date: 19 Sep 25
Bajaj Healthcare Ltd has announced 5:10 stock split, ex-date: 28 Sep 21
Bajaj Healthcare Ltd has announced 1:1 bonus issue, ex-date: 09 Apr 19
No Rights history available







